|
Status |
Public on Mar 01, 2013 |
Title |
Malignant Breast Cell Line:BT549 |
Sample type |
genomic |
|
|
Source name |
Malignant breast cell line, BaB/CLDNlow
|
Organism |
Homo sapiens |
Characteristics |
cell line: BT549 cell type: malignant breast cell line expression subtype: BaB/CLDNlow er: 0 pr: 0 her2: 0
|
Extracted molecule |
genomic DNA |
Extraction protocol |
DNA was extracted with TNES/PK (Tris/NaCl/EDTA/SDS/proteinase K) lysis buffer prior to sodium bisulfite conversion using the Zymo Research EZ DNA Methylation Kit.
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina Protocol for Infinium Methylation27 BeadChip.
|
|
|
Hybridization protocol |
Bisulphite-converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation27 BeadChips using the standard Illumina protocol.
|
Scan protocol |
Arrays were imaged using Illumina iScan with Illumina scanner settings for the Infinium chip.
|
Description |
BT549 0=negative; 1=positive
|
Data processing |
GenomeStudio V2011.1. Beta=M/(M+U).
|
|
|
Submission date |
Dec 14, 2012 |
Last update date |
Mar 01, 2013 |
Contact name |
leslie cope |
E-mail(s) |
cope@jhu.edu
|
Organization name |
leslie cope
|
Street address |
550 N. Broadway
|
City |
Baltimore |
State/province |
MD |
ZIP/Postal code |
21209 |
Country |
USA |
|
|
Platform ID |
GPL8490 |
Series (1) |
GSE42944 |
Genome-Wide Methylation Analysis of Breast Cancer Cell Lines |
|